ID: h-SDA-2026-04-26-gap-20260426-001521-06-
Hypothesis
Matrix Metalloproteinase-9-Mediated Claudin-5 Cleavage Drives Early Tight Junction Disruption in Neurodegeneration
Neuroinflammation triggers astrocyte and microglial MMP-9 activation, which proteolytically cleaves claudin-5, the principal tight junction protein.
neurodegeneration
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 4 oppose
✓ All Quality Gates Passed
🧪 Overview
Neuroinflammation triggers astrocyte and microglial MMP-9 activation, which proteolytically cleaves claudin-5, the principal tight junction protein. Claudin-5 fragmentation results in immediate BBB hyperpermeability. However, MMP-9 is not brain-specific (elevated in systemic inflammation), multiple MMPs can cleave claudin-5, and claudin-5 cleavage product detection is technically infeasible with current assays.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Neuroinflammation"]
B["Astrocyte / Microglial<br/>MMP-9 Activation"]
C["Claudin-5<br/>Proteolytic Cleavage"]
D["Tight Junction<br/>Disruption"]
E["BBB<br/>Breakdown"]
F["Neurovascular<br/>Uncoupling"]
A --> B
B --> C
C --> D
D --> E
E --> F
style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style B fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix3 supports4 contradicts
Supports
IL-1β-induced MMP-9 activation causes claudin-5 degradation and BBB disruption in mouse AD model
Supports
Elevated MMP-9 in AD patient CSF correlating with cognitive decline and BBB permeability markers
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — MMP9
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for MMP9 from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MMP9.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0986
Events (7d)
1
Price History
▲0.4%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF astrocyte-specific MMP-9 is genetically ablated (GFAP-Cre;MMP-9flox/flox) in an LPS-induced neuroinflammation model, THEN the magnitude of BBB permeability increase will not differ significantly fr | No significant difference in BBB permeability attenuation across cellular source of MMP-9 ablation | — no observation — | pending | 0.35 |
| IF selective MMP-9 inhibition (SB-3CT, 50 mg/kg i.p., 2x daily) is administered to 6-month-old 5xFAD mice for 4 weeks starting at disease onset, THEN brain Evans blue extravasation will decrease by ≥4 | Evans blue extravasation reduced ≥40%; claudin-5 full-length protein increased ≥30% | — no observation — | pending | 0.45 |
🔮 Falsifiable Predictions (2)
pendingconf 45%
IF selective MMP-9 inhibition (SB-3CT, 50 mg/kg i.p., 2x daily) is administered to 6-month-old 5xFAD mice for 4 weeks starting at disease onset, THEN brain Evans blue extravasation will decrease by ≥40% and claudin-5 protein levels will increase by ≥30% in cortex and hippocampus compared to vehicle-
Predicted outcome: Evans blue extravasation reduced ≥40%; claudin-5 full-length protein increased ≥30%
Falsification: No significant difference in BBB permeability or claudin-5 levels between selective MMP-9 inhibitor group and vehicle group (p>0.05), indicating MMP-9 is not necessary for claudin-5 degradation or BBB
pendingconf 35%
IF astrocyte-specific MMP-9 is genetically ablated (GFAP-Cre;MMP-9flox/flox) in an LPS-induced neuroinflammation model, THEN the magnitude of BBB permeability increase will not differ significantly from microglial-specific MMP-9 ablation (CX3CR1-Cre;MMP-9flox/flox) or global MMP-9 knockout, with all
Predicted outcome: No significant difference in BBB permeability attenuation across cellular source of MMP-9 ablation
Falsification: Astrocyte-specific MMP-9 knockout reduces BBB permeability by >50% while microglial-specific knockout shows no effect, disproving the hypothesis that astrocyte-derived MMP-9 is the primary driver of c
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.